Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
British Journal of Haematology
|
June 10, 2000
Differential effect of interferon alpha on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co-culture context: role of the flt3 ligand
A Solanilla, A El Andaloussi, C Grosset, et al.
Leukemia
|
April 18, 2002
Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron
H Ferry-Dumazet, M Mamani-Matsuda, M Dupouy, et al.
Blood
|
November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse
D Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation
|
January 1, 1993
Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques
F Viard, P Merel, C Bilhou-Nabera, et al.
The Journal of Laboratory and Clinical Medicine
|
November 18, 2000
Comparative methodologic study of NFkappaB activation in cultured endothelial cells
P Mercié, F Belloc, C Bihlou-Nabera, et al.
Leukemia & Lymphoma
|
December 1, 1993
Treatment of relapsed acute myeloid leukemia using GM-CSF before intensive chemotherapy
M Puntous, F Lacombe, P Dumain, et al.
Histopathology
|
February 21, 2006
Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features
M Parrens, M-A Belaud-Rotureau, O Fitoussi, et al.
Nouvelle Revue Francaise D'Hematologie
|
February 1, 1993
Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience
J Reiffers, A M Stoppa, M Attal, et al.
Leukemia
|
September 1, 1995
Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group
N Dastugue, C Payen, M Lafage-Pochitaloff, et al.
Leukemia & Lymphoma
|
January 1, 1993
Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 cases
J Reiffers, M Montastruc, G Marit, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
British Journal of Haematology
|
June 10, 2000
Differential effect of interferon alpha on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co-culture context: role of the flt3 ligand
A Solanilla, A El Andaloussi, C Grosset, et al.
Leukemia
|
April 18, 2002
Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron
H Ferry-Dumazet, M Mamani-Matsuda, M Dupouy, et al.
Blood
|
November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse
D Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation
|
January 1, 1993
Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques
F Viard, P Merel, C Bilhou-Nabera, et al.
The Journal of Laboratory and Clinical Medicine
|
November 18, 2000
Comparative methodologic study of NFkappaB activation in cultured endothelial cells
P Mercié, F Belloc, C Bihlou-Nabera, et al.
Leukemia & Lymphoma
|
December 1, 1993
Treatment of relapsed acute myeloid leukemia using GM-CSF before intensive chemotherapy
M Puntous, F Lacombe, P Dumain, et al.
Histopathology
|
February 21, 2006
Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features
M Parrens, M-A Belaud-Rotureau, O Fitoussi, et al.
Nouvelle Revue Francaise D'Hematologie
|
February 1, 1993
Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience
J Reiffers, A M Stoppa, M Attal, et al.
Leukemia
|
September 1, 1995
Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group
N Dastugue, C Payen, M Lafage-Pochitaloff, et al.
Leukemia & Lymphoma
|
January 1, 1993
Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 cases
J Reiffers, M Montastruc, G Marit, et al.
Page
of 11